/* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .footer { background: #f5f5f6; color: #555a62; font-size: 14px; line-height: 1.5; padding: 18px 0; } .footer-wrap { padding-left: 18px; padding-right: 18px; max-width: 1236px; margin: 0 auto; } .footer a { color: #0291db; } .footer a:hover { color: #0276b3; } .footer-row { display: flex; flex-wrap: wrap; justify-content: space-between; align-items: center; margin: -3px; } .footer-col { padding: 0 3px; } .footer-col-copyRight { justify-content: flex-start; } .footer-col-logo { justify-content: flex-end; } .footer-col-copyRight, .footer-col-logo { flex: 1; display: flex; } .logo { width: 120px; height: 28px; opacity: 0.6; } @media screen and (max-width: 768px) { .footer-row { display: block; } .footer-col { width: 100%; text-align: center; margin: 6px 0; } .footer-col:first-child { margin-top: 0; } .footer-col:last-child { margin-bottom: 0; } .footer-col-copyRight, .footer-col-logo { justify-content: center; } .logo { margin: 0 auto; } } /*# sourceMappingURL=styles.css.map */ /* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .region.region-footer { background-color: #1E1E23; padding: 20px; text-align: center; } .region.region-footer .block { max-width: 1264px; margin: 10px auto; color: #dddddd; } .region.region-footer .block a { color: #dddddd; font-size: 17px; } .region.region-footer .block a:hover, .csnfooter.small:hover { color: #ffffff; } #footer-links span.sep { color: rgb(151, 174, 206); font-size: 8px; display: inline-block; margin: 0 10px; line-height: 18px; vertical-align: text-top; } .csnfooter.small { font-size: 13px; margin-bottom: 15px; text-align: center; } @media only screen and (min-width: 768px) { .csnfooter.small { width: calc(100% - 348px); } } /*# sourceMappingURL=styles.css.map */ <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W7KNSFJ" height="0" width="0" style="display:none;visibility:hidden"></iframe>

Please remember that these discussion boards are a public forum, which means open to the public (i.e. non-CSN members) and the content can be found via internet search engines. Members are strongly advised not to share personal identifiers such as real names, email address, telephone number, street address, etc. This information can be used to identify you and link you to the content you provide. Other areas of CSN are restricted to members only and cannot be found by search engines.

Peritoneal Cancer

Archives for June 2014

Gemzar vs toptecan
And now for my latest recurrence of my Primary Peritoneal Ca stage 3b.... I took a 2 month chemo break even though I had some residual disease on ct. My ca125 was normal. During those 2 months, my partner was admitted to ICU for respiratory failure due to an opportunistic infection. I belueve that the incredible stress of…
Elesclomol Sodium/Paclitaxel clinical trial-- any info?
Hi, everyone. New to this board and looking for some information. I have been reading many of your posts and it has helped me a great deal. Positive thoughts going out to all of you! My mom was diagnosed on 8/5/13 with unstaged grade II PPC. Had a "good" de-bulking surgery and 6 cycles of dose-dense chemo (Taxol and…
Sue (sk_Nebraska) how are you doing?
We haven't heard from you since your surgery in April. I hope you've recovered and are doing well. Please come back and update us. Many hugs, Alexandra
Hyperthermia in Germany - Request experiences & Clinic info.
Although I was diagnosed as having Stage IV adenocarcinoma of the colon with mets to the peritoneum, my CA19-9 marker is above 40,000 (as of 4/28/2014) which is more typical of other cancers, possibly including cancer of the peritoneum. I have no elevation of the CEA marker. I have only months to live as my cancer has…
happy news . . . .
Just wanted to pass along that my CA 125 number, after my latest recurrence of PPC, is down to 74 & descending at a rate that may put me in the NORMAL range next time it's measured in 3 wks! I'm thrilled. After my 3-mo "chemo holiday" Jan--March, CA 125 was up to 327. After 1 infusion of Carboplatin, it went down to 165; &…

/* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .footer { background: #f5f5f6; color: #555a62; font-size: 14px; line-height: 1.5; padding: 18px 0; } .footer-wrap { padding-left: 18px; padding-right: 18px; max-width: 1236px; margin: 0 auto; } .footer a { color: #0291db; } .footer a:hover { color: #0276b3; } .footer-row { display: flex; flex-wrap: wrap; justify-content: space-between; align-items: center; margin: -3px; } .footer-col { padding: 0 3px; } .footer-col-copyRight { justify-content: flex-start; } .footer-col-logo { justify-content: flex-end; } .footer-col-copyRight, .footer-col-logo { flex: 1; display: flex; } .logo { width: 120px; height: 28px; opacity: 0.6; } @media screen and (max-width: 768px) { .footer-row { display: block; } .footer-col { width: 100%; text-align: center; margin: 6px 0; } .footer-col:first-child { margin-top: 0; } .footer-col:last-child { margin-bottom: 0; } .footer-col-copyRight, .footer-col-logo { justify-content: center; } .logo { margin: 0 auto; } } /*# sourceMappingURL=styles.css.map */ /* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .region.region-footer { background-color: #1E1E23; padding: 20px; text-align: center; } .region.region-footer .block { max-width: 1264px; margin: 10px auto; color: #dddddd; } .region.region-footer .block a { color: #dddddd; font-size: 17px; } .region.region-footer .block a:hover, .csnfooter.small:hover { color: #ffffff; } #footer-links span.sep { color: rgb(151, 174, 206); font-size: 8px; display: inline-block; margin: 0 10px; line-height: 18px; vertical-align: text-top; } .csnfooter.small { font-size: 13px; margin-bottom: 15px; text-align: center; } @media only screen and (min-width: 768px) { .csnfooter.small { width: calc(100% - 348px); } } /*# sourceMappingURL=styles.css.map */

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2023 © Cancer Survivors Network